Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Pembrolizumab and Olaparib in Cervical Cancer Patients
Phase 2
Terminated
- Conditions
- Cervical CancerCervical Carcinoma
- Interventions
- First Posted Date
- 2020-07-23
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Baptist Health South Florida
- Target Recruit Count
- 8
- Registration Number
- NCT04483544
- Locations
- 🇺🇸
Miami Cancer Institute, Miami, Florida, United States
🇺🇸Miami Cancer Institute at Plantation, Plantation, Florida, United States
News
No news found